Medgenics to Present at Two Upcoming Healthcare Investor Conferences

WAYNE, Pa. and MISGAV, Israel, June 16, 2014 (GLOBE NEWSWIRE) — Medgenics, Inc. (NYSE MKT:MDGN), the developer of a novel platform technology for the sustained production and delivery of therapeutic proteins in patients using ex vivo gene therapy and their own tissue for the treatment of rare and orphan diseases, today announced that members of the senior management team will be participating in the following upcoming healthcare investor conferences.

This entry was posted in Recent Development News: Q2 - 2014. Bookmark the permalink.